Riskpilot← Back to searchSign inGet full accessMED-EQ AS
ASActiveOrg 915462332Farmannsveien 18, 3111 TønsbergBusiness and other management consultancy activities · NACE 7020Est. 20152 employees
Revenue 2025
NOK 4,8M
+9% vs 2024
EBITDA margin
21.1%
+3521% vs 2024
Equity ratio
8.0%
Financial strength
Net profit 2025
NOK 792K
+2412% vs 2024
| Revenue | NOK 4,8M | +9% |
| EBITDA | NOK 1M | +3521% |
| Net profit | NOK 792K | +2412% |
| Total assets | NOK 6,7M | +79% |
| Equity | NOK 536K | -1% |
| Employees | 2 | — |
Legal name
MED-EQ AS
Org number
915462332
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
1. juni 2015
Share capital
NOK 156 250
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder eller daglig leder hver for seg.
Company purpose
Investere i verdipapirer, patenter, fast eiendom og ting som hører naturlig inn under dette.
Address
Farmannsveien 18, 3111 Tønsberg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 600 | 4 400 | 4 800 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −4 045 | −3 487 |
| EBITDA | 0 | −18 | −52 | −7 | −7 | −7 | −7 | −9 | 457 | 28 | 1 013 |
| Depreciation & amort. | −40 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −40 | −18 | −52 | −7 | −7 | −7 | −7 | −9 | 457 | 28 | 1 013 |
| Net financials | 2 | 3 | 2 | 2 | 4 | 4 | 4 | 4 | −1 | 13 | 3 |
| Profit before tax | −38 | −15 | −50 | −5 | −4 | −4 | −4 | −5 | 456 | 41 | 1 016 |
| Tax | −10 | −3 | −11 | −1 | −1 | −1 | −1 | −1 | 100 | 9 | 224 |
| Net profit | −29 | −12 | −39 | −4 | −3 | −3 | −3 | −4 | 355 | 32 | 792 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 128 | 116 | 156 | 156 | 156 | 153 | 156 | 156 | 2 222 | 3 732 | 6 681 |
| Equity | 128 | 116 | 156 | 156 | 156 | 153 | 156 | 156 | 512 | 543 | 536 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 974 | 1 579 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 737 | 1 610 | 1 573 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 711 | 3 189 | 6 146 |
EBITDA margin
21.1%
This company
15.8%
Market median
+34% vs market
20152025
Equity ratio
8.0%
This company
38.2%
Market median
-79% vs market
20152025
Return on equity
147.9%
This company
18.4%
Market median
+704% vs market
20152025
Net profit margin
16.5%
This company
8.1%
Market median
+104% vs market
20152025
Asset turnover
0.72×
This company
1.12×
Market median
-36% vs market
20152025
Debt / equity
11.48×
This company
0.62×
Market median
-1752% vs market
20152025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-02-25 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KE Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
NA Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2015 | — | — | |
| Chairman | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Immitec Norge As | Company | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Immitec Norge As
MED-EQ AS Board members of MED-EQ AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjell Einar Jakobsen | Chief Executive Officer | 0 companies |
| Nikolaos Avgerinos | Chief Executive Officer | 0 companies |
| Jan Johansen | Chairman | 0 companies |
| Sølvi Holte | Chairman | 0 companies |